Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Mitochondrial alterations in humanized ARMS2A69S variant mouse model of age-related macular degeneration (AMD)
Author Affiliations & Notes
  • Navdeep Gogna
    The Jackson Laboratory, Bar Harbor, Maine, United States
  • Gayle B Collin
    The Jackson Laboratory, Bar Harbor, Maine, United States
  • Lillian F Hyde
    The Jackson Laboratory, Bar Harbor, Maine, United States
  • Lisa Stone
    The Jackson Laboratory, Bar Harbor, Maine, United States
  • Jürgen K Naggert
    The Jackson Laboratory, Bar Harbor, Maine, United States
  • Patsy M Nishina
    The Jackson Laboratory, Bar Harbor, Maine, United States
  • Footnotes
    Commercial Relationships   Navdeep Gogna None; Gayle Collin None; Lillian Hyde None; Lisa Stone None; Jürgen Naggert None; Patsy Nishina None
  • Footnotes
    Support  THOME Foundation, Brightfocus M2023001F
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3809. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Navdeep Gogna, Gayle B Collin, Lillian F Hyde, Lisa Stone, Jürgen K Naggert, Patsy M Nishina; Mitochondrial alterations in humanized ARMS2A69S variant mouse model of age-related macular degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2024;65(7):3809.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A humanized ARMS2 mouse model was developed to examine the contribution of the ARMS2 rs10490924, pAla69Ser,risk allele to age-related macular degeneration (AMD). ARMS2A69S and its wild-type ARMS2A69 counterpart were generated on the C57BL/6J background using CRISPR/Cas9 technology. The ARMS2 gene was inserted into a non-coding site that is homologous between humans and mice, upstream of the mouse Htra1 gene. A native promoter was used to preserve hARMS2 regulatory regions. The aim of this study was to identify the early changes in ARMS2A69S mice that ultimately may result in AMD-like phenotypes with aging.

Methods : RNA-sequencing was performed to compare the transcriptome of 14-day old ARMS2A69S mutant mice to that of C57BL/6J (B6J) controls. A69S allele specific changes were verified by performing qRT-PCR on selected genes on ARMS2A69S, wild-type ARMS2A69 and B6 mice. Altered mitochondrial function was assessed by measuring NAD/NADH ratios using a calorimetric assay in 6-month-old mice.

Results : Transcriptomic analysis showed significant downregulation of multiple mitochondria-associated genes including Nd2, Nd4, Cytb, Cox1, Atp5a1 and Ndufa7 in retina and RPE enriched tissue fractions from ARMS2A69S mice as compared to B6J controls. Further, qRT-PCR confirmed that the expression of mitochondria-associated genes was significantly lower in ARMS2A69S mice as compared to both B6J and wild-type ARMS2A69 WT mice. To test if the altered mitochondrial gene expression had a functional effect, NAD+ levels and NAD+/NADH ratios were obtained and compared. The results confirmed that the eyecups isolated from ARMS2A69S mutants had significantly lower total NAD+ levels than B6J controls and lower NAD+/NADH ratios than both B6J and ARMS2A69 WT mice.

Conclusions : Our initial analysis suggests early mitochondrial alterations may contribute to AMD-like phenotypes observed in aged ARMS2A69S mice. A complete characterization of structural and functional changes in mitochondria are underway to identify the major mitochondrial pathways affected by the ARMS2A69S AMD risk allele. Unravelling such networks will provide a basis for furthering our understanding of the role of mitochondrial dysfunction leading to AMD-associated phenotypes.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×